Net loss attributed to Nuvi common stockholders decreased in the Q3 of 2024 to $1,600,000 from a net loss of $8,600,000 in the Q3 of 2023. The $6,900,000 improvement was a result of higher gross margins of $700,000 lower operating expenses of $5,900,000 and increased other income of 300,000 Now turning to our balance sheet, we had approximately $300,000 in cash as of September 30, 2024, excluding $500,000 in restricted cash, which represents a decrease of $1,100,000 from June 30, 2024. The $1,100,000 decrease in cash was a result of cash operating losses of $1,000,000 negative working capital of $2,600,000 offset by $2,500,000 in cash received from the issuance of short term promissory notes. Subsequent to the quarter ended September 30, 2024, we received an additional 3 $100,000 in proceeds from the issuance of convertible notes this October, which will be paid off in monthly payments with interest in either cash or equity beginning in February 2025 through April 2026. During the quarter, inventories decreased by $300,000 to $5,700,000 at September 30, 2024 as we continue to reduce inventory levels.